🔎 Trials Near Me

ホーム › 非小細胞肺癌 › モンタナ州 › Billings

Billings、MTにおける非小細胞肺癌の臨床試験

Billingsとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

被験者募集中第3相
  • St. Vincent Frontier Cancer Center-Research ( Site 0105), Billings
18歳以上 · 全性別 · 2026/10/05更新 · NCT06345729

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

被験者募集中第3相
  • Billings Clinic Cancer Center, Billings
18歳以上 · 全性別 · 2026/10/05更新 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

被験者募集中第3相
  • Billings Clinic Cancer Center, Billings
18歳以上 · 全性別 · 2026/10/05更新 · NCT04267848

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

被験者募集中第3相
  • Billings Clinic ( Site 3255), Billings
18歳以上 · 全性別 · 2026/10/01更新 · NCT07513376

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

被験者募集中第3相
  • Billings Clinic Cancer Center, Billings
  • Saint Vincent Frontier Cancer Center, Billings
18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

被験者募集中第3相
  • St. Vincent Frontier Cancer Center, Billings
18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

被験者募集中第3相
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana, Billings
18歳以上 · 全性別 · 2026/09/28更新 · NCT07144280

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

被験者募集中第3相
  • SCL Health - Montana, Billings
  • SCL Health - Montana, Billings
18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

被験者募集中第2相
  • Billings Clinic Cancer Center, Billings
18歳以上 · 全性別 · 2026/09/24更新 · NCT03191149

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

被験者募集中第2相
  • St. Vincent Frontier Cancer Center, Billings
18歳以上 · 全性別 · 2026/08/26更新 · NCT07288177

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

被験者募集中第1/2相
  • Intermountain Health - St. Vincent Frontier Cancer Center, Billings
18歳以上 · 全性別 · 2026/06/30更新 · NCT06162221

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

被験者募集中第2相
  • Billings Clinic Cancer Center, Billings
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2相
  • Billings Clinic Cancer Center, Billings
18歳以上 · 全性別 · 2026/05/06更新 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2/3相
  • Billings Clinic Cancer Center, Billings
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2相
  • Billings Clinic Cancer Center, Billings
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

被験者募集中観察研究
  • Billings Clinic Cancer Center, Billings
  • Montana Cancer Consortium NCORP, Billings
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

被験者募集中観察研究
  • Massive Bio SYNERGY-AI site, Billings
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

他の都市における非小細胞肺癌の試験

Billingsにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。